| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 01/03/2003 | WO2003000289A1 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases |
| 01/03/2003 | WO2003000181A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2002088101A3 Inhibitors of bace |
| 01/03/2003 | WO2002083062A3 Process for the production of piperidine derivatives with microorganisms |
| 01/03/2003 | CA2450758A1 Composition comprising a pde-4 inhibitor and h1-receptor antagonist and the use thereof for the manufacture of a medicament for the treatment of respiratory diseases |
| 01/03/2003 | CA2450475A1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/02/2003 | US20030004352 Contacting a racemic mixture of the piperidine carbinol in solution with ditoluoyltartaric acid, crystallising the salt and neutralizing |
| 01/02/2003 | US20030004340 Skin disorders; gastrointestinal disorders |
| 01/02/2003 | US20030004308 Anticoagulants |
| 01/02/2003 | US20030004187 Method for preventing dyskinesias |
| 01/02/2003 | US20030004185 Viricides, organ transplants, antiarthritic agents |
| 01/02/2003 | US20030004169 Modulators of dopamine neurotransmission |
| 01/02/2003 | US20030004151 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/02/2003 | EP1270549A1 Polymer-immobilized alpha-iminoester |
| 01/02/2003 | EP1270547A1 Novel phenylalanine derivative |
| 01/02/2003 | EP1268469A1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants |
| 01/02/2003 | EP1268454A1 Succinoylamino heterocycles as inhibitors of a-beta protein production |
| 01/02/2003 | EP1268426A1 4-formyl amino-n-methylpiperidine derivatives, the use thereof as stabilisers and organic material stabilised therewith |
| 01/02/2003 | EP1268412A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 01/02/2003 | EP1267878A2 Compounds with 5-ht activity useful for controlling visual field loss |
| 01/02/2003 | EP1219614A9 Benzene sulfonamides as PDE-V inhibitors for the use against erectile dysfunction |
| 01/02/2003 | EP1149832B1 Benzamide derivatives and drugs containing the same |
| 01/02/2003 | EP1030831A4 Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
| 01/02/2003 | EP1019374B1 Polymorphs of donepezil hydrochloride and process for production |
| 01/02/2003 | EP0804431B9 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 01/02/2003 | EP0705245B1 Novel intermediates for the preparation of antihistaminic 4-diphenylmethyl/diphenylmethoxy piperidine derivatives |
| 12/31/2002 | US6500863 Interleukin binding inhibitors such as n-(2-hydroxyl-3-amino sulfonyl-4-chlorophenyl)-n'-(2-bromophenyl)urea, used for prophylaxis of chemokine mediated diseases |
| 12/31/2002 | US6500844 Cyclopentyl modulators of chemokine receptor activity |
| 12/31/2002 | US6500843 Inhibitors of rotamase enzyme activity |
| 12/31/2002 | US6500841 Inhibitors of farnesyl-protein transferase |
| 12/31/2002 | US6500832 Administering enzyme inhibitors as viricides for prophylaxis of viral diseases such as aquired immune deficiency syndrome |
| 12/31/2002 | US6500825 Substituted 2-aminoacetamides and the use thereof |
| 12/31/2002 | US6500823 Energy deficiency of the cell caused by parp inhibition, in diabetes complications, in oxygen deficient status of the heart and brain, in neurodegenerative diseases, in the treatment of autoimmune and/or viral diseases |
| 12/31/2002 | US6500822 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists |
| 12/31/2002 | US6500818 Naphthalenecarboxamides as tachykinin receptor antagonists |
| 12/31/2002 | US6500803 Factor VIIa inhibitors |
| 12/31/2002 | US6500303 Inhibition of pulp and paper yellowing using nitroxides, hydroxylamines and other coadditives |
| 12/31/2002 | CA2227814C Substituted benzylaminopiperidine compounds |
| 12/27/2002 | WO2002102983A2 Oligomers and polymers of di-substituted cyclic imino carboxylic acids |
| 12/27/2002 | WO2002102777A2 NOVEL CRYSTALLINE FORMS OF 4-[4-[4-(HYDROXYDIPHENYLMETHYL)-1-PIPERINDINYL]-1-HYDROXYBUTYL]-α, α-DIMETHYLBENZENE ACETIC ACID AND ITS HYDROCHLORIDE |
| 12/27/2002 | WO2002102776A1 Process for the production of the piperidine derivative fexofenadine |
| 12/27/2002 | WO2002102775A1 Derivatives of 3-phenyl-n-(2- (4-benzyl) piperidin-1-yl)-ethyl)-acrylamid with ccr-3 receptor antagonistic activity for use in the treatment of inflammations and allergic conditions |
| 12/27/2002 | WO2002102743A2 DEUTERATED N-SUBSTITUTED AND α-SUBSTITUTED DIPHENYLALKOXY ACETIC ACID AMINO ALKYL ESTERS AND MEDICAMENTS CONTAINING THESE COMPOUNDS |
| 12/27/2002 | WO2002102381A1 Acylic piperazine and piperidine derivatives which are useful for treating neuronal damage |
| 12/27/2002 | WO2002102380A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors |
| 12/27/2002 | WO2002102372A1 Gem-disubstituted cyclohexane derivatives and their use as therapeutic agents |
| 12/27/2002 | WO2002070473A3 Carboxamide derivatives as therapeutic agents |
| 12/27/2002 | CA2646802A1 Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-.alpha.,.alpha.-dimethylbenzene acetic acid and its hydrochloride |
| 12/27/2002 | CA2451638A1 Deuterated n-substituted and .alpha.-substituted diphenylalkoxy acetic acid amino alkyl esters and medicaments containing these compounds |
| 12/27/2002 | CA2450074A1 Acylic piperazine and piperidine derivatives which are useful for treating neuronal damage |
| 12/27/2002 | CA2429113A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors |
| 12/26/2002 | US20020198407 Antiallergy agents and bronchodilators |
| 12/26/2002 | US20020198234 Identifying a patient suffering from fatigue arising from oncological condition, and administering to the patient a therapeutically effective amount of D-threo-methylphenidate free of 1-threo isomer |
| 12/26/2002 | US20020198233 Process for the preparation of 4-[1-hydroxy-4-[4-(hydroxydiphenylmethly)-1-piperidinyl]-butyl]-alpha,alpha-dimethylbenzeneacetic acid |
| 12/26/2002 | US20020198225 Administering a competitive inhibitor of the enzyme in an amount effective to enhance enzyme activtiy, selected from 2,5-dideoxy- 2,5-imino-D-mannitol, 3,4-diepi- alpha -homonojirimycin, 5-O- deoxyglactonojirimycin, calystegines |
| 12/26/2002 | US20020198214 Such as (3-(4-(4-fluoro-benzyl)-piperidine-1-carbonyl)-4-methoxy-phenyl)-oxo-acetic acid methyl ester for proinflammation response in multiple sclerosis, inflammatory bowel disease, osteoarthritis, and other arthritic conditions |
| 12/26/2002 | US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa |
| 12/26/2002 | US20020198156 Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor |
| 12/25/2002 | CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 12/25/2002 | CN1097052C Process for production of amidinoindole derivs, and salts thereof |
| 12/24/2002 | US6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/24/2002 | US6498273 For imaging organs or structures including blood vessels, a thrombus within a vessel, heart, brain, kidney, liver, lungs, spleen, etc., meidcal diagnosis |
| 12/24/2002 | US6498255 Cholinesterase inhibitors; cognition activators; alzheimer's disease; e.g., 3-(2-(1-(phenylmethyl)-4-piperidinyl)ethyl)-1,2-benzisoxazole |
| 12/24/2002 | US6498170 4-((2s)-3-(1-(4-butoxy-benzenesulfonyl)-azetidin-3-ylamino)-2 -hydroxy- propoxy)-phenol for example; hypoglycemic agent; increasing lean meat to fat ratio in mammals |
| 12/24/2002 | US6498169 Cyclic amine compounds and pharmaceutical composition containing the same |
| 12/24/2002 | US6498168 Muscarinic antagonists |
| 12/24/2002 | US6498162 Treating inflammatory and allergic diseases of respiratory tract and diseases of central nervous system |
| 12/24/2002 | US6497886 1,3-bis-(N-lactamyl) propane and the pharmaceutical and cosmetic use thereof |
| 12/19/2002 | WO2002101003A2 Stereoselective preparation of cyclic l-amino acids |
| 12/19/2002 | WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 12/19/2002 | WO2002100848A1 Novel phenylalkyl diamine and amide analogs |
| 12/19/2002 | WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 12/19/2002 | WO2002100831A1 4-imino-n-alkoxy or oxy-polyalkyl-piperidine compounds and their use as polymerization regulators |
| 12/19/2002 | WO2002100829A2 Process for the preparation of paroxetine substantially free of alkoxy impurities |
| 12/19/2002 | WO2002100822A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 12/19/2002 | WO2002100814A1 Method for producing (meth)acrylic acid esters |
| 12/19/2002 | WO2002100344A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 12/19/2002 | WO2002070541A3 Peptide deformylase inhibitors |
| 12/19/2002 | WO2002060894A3 Sulfonamide lactam inhibitors of factor xa |
| 12/19/2002 | US20020193614 Treatment of cardiovascular disorders |
| 12/19/2002 | US20020193605 Selectively inhibits action of N-type calcium channel; treatment of ischemic cerebrovascular disorders caused by cerebral infarction or intracerebral bleeding, Alzheimer's disease, AIDS related dementia, Parkinson's disease |
| 12/19/2002 | US20020193603 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 12/19/2002 | US20020193602 Opioid receptor antagonists and agonists; for example, a 1-(arylcarbonylaminoalkyl),3,4-dimethyl-4-(3-hydroxyphenyl)-piperidine compound of given formula |
| 12/19/2002 | US20020193601 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof |
| 12/19/2002 | US20020193600 Preparing anhydrous 4-(4-(4-(Hydroxydiphenylmethyl)-1-piperidinyl)-1-hydroxybutyl)-alpha,alpha- dimethylbenzene acetic acid hydrochloride by azeotropic distillation of the corresponding hydrate |
| 12/19/2002 | US20020193599 Dihydropyridines and new uses thereof |
| 12/19/2002 | US20020193596 Inhibitors of protein isoprenyl transferases |
| 12/19/2002 | US20020193432 Useful as modulators of the interaction between the receptor for advanced glycated end product and its ligands |
| 12/19/2002 | US20020193420 Neurotrophic, low molecular weight, small molecule heterocyclic ketone or thioester compounds are nonimmunosuppressive, has an affinity for FKBP type immunophilins |
| 12/19/2002 | US20020192292 Microparticulate form of a tetrahydropyridin derivative |
| 12/19/2002 | US20020189033 Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same |
| 12/19/2002 | CA2457382A1 Process for the preparation of paroxetine substantially free of alkoxy impurities |
| 12/19/2002 | CA2450271A1 Novel phenylalkyl diamine and amide analogs |
| 12/19/2002 | CA2445653A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 12/19/2002 | CA2443718A1 4-imino-n-alkoxy or oxy-polyalkyl-piperidine compounds and their use as polymerization regulators |
| 12/18/2002 | EP1266896A1 Linear ou cyclic ureas, process for their preparation and pharmaceutical compositions containing them |
| 12/18/2002 | EP1266654A1 Stabilised amlodipine maleate formulations |
| 12/18/2002 | EP1265864A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 12/18/2002 | EP1265863A1 Heterocyclic side chain containing metalloprotease inhibitors |
| 12/18/2002 | EP1265641A2 Imaging agents for diagnosis of parkinson's disease |